glp-1/gip/glucagon receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Glucagon-like Peptide-1 Receptor (GLP-1R) Signaling:
Description
Endocrinology 2008
Business of the American Medical Association House of Delegates 2013 Annual Meeting annotated reference committee reports: reference committee D
2 Treatment for type 2 diabetes is initiated based on (glycated hemoglobin) HbA1C levels, treatment goals, and cardiovascular, renal, as well as hypoglycemia risk
Naresh Trehan on the Risks of GLP-1 drugs Dr
Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J
In order to be able to address these, businesses will need to understand: What GLP-1RAs are, how they are used and how they are likely to evolve going forward
